Publication | Closed Access

Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC)

Adaptive RadiotherapyFinal ResultsRadiation MedicineRadiation TherapyMedicineHyperfractionated-accelerated VersusAro 97-1OncologyRadiation OncologyLung CancerRadiologyHealth Sciences